Publications by authors named "Mei-zhen Zhou"
Background: Patients with colorectal cancer may need postoperative nursing to improve prognosis, and conventional nursing is not effective. Clinical research is needed to explore nursing methods that can more effectively improve postoperative conditions on colorectal cancer patients undergoing colostomy.
Aim: To explore the effect of internet multiple linkage mode-based extended care combined with in-hospital comfort care on colorectal cancer patients undergoing colostomy.
Article Synopsis
- Allogeneic hematopoietic stem cell transplantation is a common and effective treatment for blood-related diseases, reliant on finding HLA-matched donors.
- A study examined HLA allele and haplotype distributions among 169,995 Chinese individuals, revealing the presence of many distinct alleles and significant regional variations in haplotype frequencies.
- This research, the first of its kind in China, provides valuable data for improving donor matching processes and contributes to understanding genetic diversity across different regions in the country.
[Efficacy and safety of bevacizumab plus capecitabine for metastatic colorectal cancer].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
August 2010
Objective: To evaluate the efficacy and safety of bevacizumab plus capecitabine in treating metastatic colorectal cancer(mCRC).
Methods: Eleven patients with mCRC (6 females and 5 males) were enrolled in this study. Bevacizumab was given with 5 mg/kg every two weeks in five patients, 10 mg/kg every two weeks in four patients and 15 mg/kg every three weeks in two patients.
Objective: To investigate the efficacy, safety and the life quality improvement of uroacitides injection in the treatment for patients with advanced malignant tumors.
Methods: A total of 160 patients with advanced stage cancers were enrolled into this multicenter, open and non-randomized phase II clinical trial, including cancers of the lung (33 cases), liver (45 cases), breast (17 cases), esophagus (11 cases), stomach (18 cases), colon (19 cases), pancreas (3 cases) and kidney (4 cases), and glioma (10 cases). Uroacitides was administrated in a dose of 300 ml daily via the superior vena cava catheter for consecutive 4-8 weeks.
Background & Objective: Atofloding (ATFU) is a new derivative of 5-fluorouracil. The phase I and II clinical study have been finished. The current study was a phase III clinical trail of ATFU.
View Article and Find Full Text PDF